Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 2146 AL 2160

[Dementia with Lewy bodies: old and new knowledge-Part 2: treatment]

Dodel R, Berg D, Duning T, Kalbe E, Meyer PT, Ramirez A, Storch A, Aarsland D, Jessen F.

Nervenarzt. 2024 Apr;95(4):362-367. doi: 10.1007/s00115-023-01577-2. Epub 2023 Dec 14.

Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases

Balestri W, Sharma R, da Silva VA, Bobotis BC, Curle AJ, Kothakota V, Kalantarnia F, Hangad MV, Hoorfar M, Jones JL, Tremblay MÈ, El-Jawhari JJ, Willerth SM, Reinwald Y.

J Neuroinflammation. 2024 Jan 23;21(1):32. doi: 10.1186/s12974-024-03024-8.

14-3-3 protein and its isoforms: A common diagnostic marker for Alzheimer's disease, Parkinson's disease and glaucomatous neurodegeneration

Panda SP, Kesharwani A, Singh B, Marisetti AL, Chaitanya M, Dahiya S, Ponnusankar S, Kumar S, Singh M, Shakya PK, Prasad PD, Guru A.

Ageing Res Rev. 2024 Dec;102:102572. doi: 10.1016/j.arr.2024.102572. Epub 2024 Nov 1.

The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson's Disease: A Promising Therapeutic Approach

So YJ, Lee JU, Yang GS, Yang G, Kim SW, Lee JH, Kim JU.

Int J Mol Sci. 2024 Jan 15;25(2):1071. doi: 10.3390/ijms25021071.

White matter injury across neurodegenerative disease

Festa LK, Grinspan JB, Jordan-Sciutto KL.

Trends Neurosci. 2024 Jan;47(1):47-57. doi: 10.1016/j.tins.2023.11.003. Epub 2023 Dec 4.

The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer's and Parkinson's Diseases

Czarnik W, Fularski P, Gajewska A, Jakubowska P, Uszok Z, Młynarska E, Rysz J, Franczyk B.

Nutrients. 2024 Jan 19;16(2):308. doi: 10.3390/nu16020308.

Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases

Rymbai E, Sugumar D, Chakkittukandiyil A, Kothandan R, Selvaraj D.

Cell Biochem Funct. 2024 Apr;42(3):e4014. doi: 10.1002/cbf.4014.

Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects

Tong B, Ba Y, Li Z, Yang C, Su K, Qi H, Zhang D, Liu X, Wu Y, Chen Y, Ling J, Zhang J, Yin X, Yu P.

Neurobiol Dis. 2024 Jun 15;196:106505. doi: 10.1016/j.nbd.2024.106505. Epub 2024 Apr 19.

Silent Information Regulator 1/Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Axis: A Promising Target for Parkinson's and Alzheimer's Disease Therapies

Goyal A, Kumari A, Verma A, Chaudhary V, Agrawal V, Yadav HN.

J Biochem Mol Toxicol. 2024 Dec;38(12):e70078. doi: 10.1002/jbt.70078.

Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease

Goyal A, Solanki K, Verma A.

J Biochem Mol Toxicol. 2024 Jan;38(1):e23619. doi: 10.1002/jbt.23619. Epub 2023 Dec 13.

Immunotherapy for Parkinson's Disease and Alzheimer's Disease: A Promising Disease-Modifying Therapy

Mahboob A, Ali H, AlNaimi A, Yousef M, Rob M, Al-Muhannadi NA, Senevirathne DKL, Chaari A.

Cells. 2024 Sep 12;13(18):1527. doi: 10.3390/cells13181527.

Does gut brain axis has an impact on Parkinson's disease (PD)?

Elangovan A, Dahiya B, Kirola L, Iyer M, Jeeth P, Maharaj S, Kumari N, Lakhanpal V, Michel TM, Rao KRSS, Cho SG, Yadav MK, Gopalakrishnan AV, Kadhirvel S, Kumar NS, Vellingiri B.

Ageing Res Rev. 2024 Feb;94:102171. doi: 10.1016/j.arr.2023.102171. Epub 2023 Dec 21.

Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases

Nguyen-Thi PT, Ho TT, Nguyen TT, Vo GV.

Curr Drug Deliv. 2024;21(7):917-931. doi: 10.2174/1567201820666230707113405.

Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis

Patil RS, Tupe RS.

Med Res Rev. 2024 Jan;44(1):365-405. doi: 10.1002/med.21987. Epub 2023 Aug 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias